Analytics
Dealmaker Securities
Fairness – Most popular
$155,000,000
Healthcare & Prescribed drugs
Monogram Orthopaedics, with a valuation of $155 million, is elevating funds on DealMaker Securities. The corporate is creating a product resolution structure to permit the personalization of orthopedic implants. Monogram Orthopaedics makes use of 3D printing and robotics by automated digital picture evaluation algorithms. The Monogram Knee System has received FDA approval and is fixing actual issues by revolutionizing joint alternative know-how. Dr. Douglas Unis based Monogram Orthopaedics in 2016. The present crowdfunding marketing campaign has a minimal goal of $100,000 and a most goal of $5,000,000. The marketing campaign proceeds can be used for analysis and growth.
Abstract Revenue and Loss Assertion
|
Income |
$628,246 |
$0 |
|
COGS |
$458,675 |
$0 |
|
Tax |
$0 |
$0 |
|
|
||
|
|
||
|
Web Earnings |
$-11,814,968 |
$-9,068,006 |
Abstract Stability Sheet
|
Money |
$5,535,710 |
$5,586,748 |
|
Accounts Receivable |
$0 |
$0 |
|
Complete Property |
$8,715,366 |
$8,115,888 |
|
Quick-Time period Debt |
$0 |
$0 |
|
Lengthy-Time period Debt |
$0 |
$0 |
|
Complete Liabilities |
$0 |
$0 |
Financials as of: 07/15/2022
Elevate Historical past
| Monogram Orthopedics (previously Monogram Orthopaedics) | 10/31/2022 | Dealmaker Securities | $155,000,000 | $0 | Fairness – Most popular |
Lively |
RegCF |
| Monogram Orthopaedics | 02/18/2022 | StartEngine | $89,000,000 | $23,648,853 | Fairness – Most popular |
Funded |
RegA+ |
| Monogram Orthopaedics | 01/16/2021 | StartEngine | $89,900,000 | $2,965,501 | Fairness – Most popular |
Funded |
Check the Waters / RegA+ |
| Monogram Orthopaedics | 03/31/2020 | SeedInvest | $21,250,000 | $14,588,668 | Fairness – Most popular |
Funded |
RegA+ |
Pay Month-to-month
Yearly (Save 17%)
-
$12.42 /month
billed yearly - Free portfolio monitoring and KingsCrowd’s quantitative rankings on all raises.
- Plan Consists of:
-
All the things in Free, plus
- Firm particular
“>
KingsCrowd rankings (excluding danger)
- Superior firm search (
with rankings) 
“>
Markets web page filters and historic trade knowledge-
Get Edge Annual
Edge
-
$41.58 /month
billed yearly - Full website entry together with KingsCrowd’s qualitative analyst studies.
- Plan Consists of:
- All the things in Edge, plus
- Full entry to detailed
“>
Analyst Stories (e.g. Prime Deal, Deal to Watch, Impartial, and Underweight)
Search and filter based mostly on Analyst Stories- In-depth danger rankings for each increase
-
Get Edge Professional Annual
Edge Professional
Wall Road has Morningstar, S&P, and Bloomberg
The fairness crowdfunding market has KingsCrowd.
Analyst Report 
Larger precision and sooner surgical procedures. That’s the secret with Monogram.
At first look, this will appear too futuristic (and borderline unattainable).
I’m right here to inform you that Monogram has almost achieved it. The corporate is conducting reside surgical demonstrations of its robotic for the orthopedic group and is gearing up for FDA submission.
As soon as the corporate’s robotic is accredited by the FDA, Monogram will launch its first-generation knee providing with generic implants. As soon as this has been efficiently rolled out to hospitals, the corporate will launch its second technology of implants: 3D-printed implants that intently match a affected person’s anatomy and stand to disrupt this area in a significant means.
Thanks to your vote on Monogram Orthopedics (previously Monogram Orthopaedics) on DealMaker Securities 2022
Thanks to your vote on Monogram Orthopedics (previously Monogram Orthopaedics) on DealMaker Securities 2022
